Is STE stock a Buy, Sell, or Hold?

Based on our analysis, STE is currently a HOLD with moderate confidence. 📊 HOLD: STE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of STE stock?

Our analysis estimates the fair value range for STE to be between $255.88 and $264.21. The current price is $264.24.

What is the analyst price target for STE?

The average Wall Street analyst price target for STE is $281.62. This implies a potential upside of 6.6% from current levels.

STE Stock Analysis: Buy, Sell, or Hold?

STE - STERIS plc

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

$264.24

1.64 (0.62%) ▲

5d: +0.42%

30d: +4.23%

90d: +11.88%

HOLD

MODERATE Confidence

Protect Your STE Gains

Last Updated: February 2, 2026

Earnings: Feb 04, 2026 1d

Get Alerted When STE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: STE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 9.1%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$377.42

Based on 6.6% avg growth

INTRINSIC VALUE TODAY

$234.35

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.7x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: STE is currently trading at $264.24, which is considered extended relative to its 30-day fair value range of $255.88 to $264.21. The stock's valuation (Forward PE: 23.7) is in line with its historical norms (24.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This pessimistic expectation contrasts with the company's recent 28.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, STE is in a strong uptrend. The price is approaching resistance at $267.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (23th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED

Fair Price Range $255.88 - $264.21

Company Quality Score 61/100 (BUY)

Options IV Signal 23th percentile (LOW)

Volume Confirmation HIGH

Confidence Score 56.5%

Protect Your Profits

Holding STE? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BULLISH: Options cheap (IV 23th percentile)
NEUTRAL: Mixed technical signals (55/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($281.62)

Fair Price Analysis

30-Day Fair Range $255.88 - $264.21

Current vs Fair Value EXTENDED

Expected Move (7 Days) ±$12.39 (4.7%)

Support & Resistance Levels

Support Level $255.69

Resistance Level $267.10

Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 23.73

Wall Street Target $281.63 (+6.6%)

Revenue Growth (YoY) 9.9%

Earnings Growth (YoY) 28.6%

Profit Margin 12.1%

Valuation Discount vs History -1.4% cheaper

PE vs Historical 23.7 vs 24.7 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -1.4% (market-implied from PE analysis)

1-Year Target $260.54 (-1%)

2-Year Target $256.89 (-3%)

3-Year Target $253.30 (-4%)

3-Yr Target (if PE normalizes) (PE: 24→25) $263.63 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 23.7, Growth: 9.1%) $343.15 (+30%)

Base: (SPY PE: 22.3, Growth: 9.1%) $322.45 (+22%)

Bear: (PE: 19.0, Growth: 9.1%) $274.08 (+4%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (24x PE) as earnings recover.

Trailing PE: 37.43 | Current EPS (TTM): $6.97

Bull Case $458.39 (+75%)

Analyst growth 59.7%, PE expands to 41.2

Base Case $416.72 (+59%)

Market implied 59.7%, PE stable at 37.4

Bear Case $177.38 (-33%)

Severe decline -20.0%, PE contracts to 31.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 23.7 to 24.7

Stabilization Target: $275.02 (+4.1%)

PE Expansion Potential: +4.1%

Last updated: February 02, 2026 4:38 PM ET
Data refreshes hourly during market hours. Next update: 5:38 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is STE showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Daniel A Carestio SELL 159 shares 2025-10-06

April McClain Delaney BUY 2025-09-18

April McClain Delaney BUY 2025-09-11

View Insider Activity Scanner

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BSX Boston Scientific Corp	STRONG BUY 34 analysts	$124	59 HOLD
DXCM DexCom Inc	STRONG BUY 26 analysts	$85	59 HOLD
MDT Medtronic PLC	BUY 32 analysts	$111	66 BUY
ABT Abbott Laboratories	BUY 28 analysts	$134	59 HOLD
PODD Insulet Corporation	STRONG BUY 23 analysts	$370	57 HOLD

BSX Boston Scientific…

ABT Abbott Laboratori…

59 HOLD

PODD Insulet Corporati…

57 HOLD

Advanced STE Option Strategies

Professional options setups generated by AI based on today's STE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for STE

STE Technical Chart STE Price Prediction STE Earnings Date STE Investment Advisor STE Fair Price Analyzer STE Options Advisor STE Options Chain STE Options Analysis STE Competitors

Compare STE with Other Stocks

COCH vs STE

ALGN vs STE
Winner: STE

Create New Comparison

Tradestie

STE Stock Analysis: Buy, Sell, or Hold?

STE - STERIS plc

Get Alerted When STE Hits Your Target Price

Interactive Price Chart (1 Month)

Long-Term Wealth Forecast (2031)

In-depth Analysis How we analyze

Quick Decision Summary

Protect Your Profits

All Signals

Fair Price Analysis

Support & Resistance Levels

Fundamental Context

🔥 Top Stocks Breaking Out Now

Top Rated Medical Devices Stocks

Advanced STE Option Strategies

More Analysis for STE

Compare STE with Other Stocks

💬 Send Us Feedback